Sulzer Medica confident with new $1 billion implants plan
This article was originally published in Clinica
Executive Summary
Sulzer Medica may be a mere few months away from settling the faulty Inter-Op hip implant saga that dogged it for all of last year and caused its share price to crumple to a fraction of its value before the event. The Swiss company has formed a new $1 billion proposed settlement after negotiations that included the plaintiffs' lawyers. Shares in the company leapt by over 20% to around SFr110 ($65) on the disclosure.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.